Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Heynen

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Rheumatology|January 1, 1989
Proteoglycan metabolism in isolated chondrocytes from human cartilage and in short-term tissue-cultured human articular cartilageG Verbruggen, E M Veys, A M Malfait, et al.
Clinical Endocrinology|December 1, 1977
Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone diseaseJ A Kanis, R G Russell, R B Naik, et al.
Digestion|January 1, 1983
Calcium metabolism in subjects living with a permanent ileostomyH J Kennedy, J Compston, G Heynen, et al.
Acta Endocrinologica|December 1, 1981
Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjectsG Heynen, F Cornet, P Franchimont, et al.
Archives of Disease in Childhood|June 1, 1977
Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferolJ A Kanis, R G Henderson, G Heynen, et al.
British Medical Journal (Clinical Research Ed.)|March 20, 1982
Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3T Cundy, J A Kanis, G Heynen, et al.
The Quarterly Journal of Medicine|January 1, 1983
Familial benign hypercalcaemia. Study of a large familyF H Menko, O L Bijvoet, J L Fronen, et al.
Journal De Chirurgie|April 1, 1983
[Rupture of the left subclavian artery associated with fracture of the 1st rib]J G Balique, Y G Heynen, M C Robert, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in manR G Russell, J A Kanis, R Smith, et al.
The Quarterly Journal of Medicine|April 1, 1979
Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responsesJ A Kanis, T Cundy, M Earnshaw, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Rheumatology|January 1, 1989
Proteoglycan metabolism in isolated chondrocytes from human cartilage and in short-term tissue-cultured human articular cartilageG Verbruggen, E M Veys, A M Malfait, et al.
Clinical Endocrinology|December 1, 1977
Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone diseaseJ A Kanis, R G Russell, R B Naik, et al.
Digestion|January 1, 1983
Calcium metabolism in subjects living with a permanent ileostomyH J Kennedy, J Compston, G Heynen, et al.
Acta Endocrinologica|December 1, 1981
Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjectsG Heynen, F Cornet, P Franchimont, et al.
Archives of Disease in Childhood|June 1, 1977
Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferolJ A Kanis, R G Henderson, G Heynen, et al.
British Medical Journal (Clinical Research Ed.)|March 20, 1982
Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3T Cundy, J A Kanis, G Heynen, et al.
The Quarterly Journal of Medicine|January 1, 1983
Familial benign hypercalcaemia. Study of a large familyF H Menko, O L Bijvoet, J L Fronen, et al.
Journal De Chirurgie|April 1, 1983
[Rupture of the left subclavian artery associated with fracture of the 1st rib]J G Balique, Y G Heynen, M C Robert, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in manR G Russell, J A Kanis, R Smith, et al.
The Quarterly Journal of Medicine|April 1, 1979
Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responsesJ A Kanis, T Cundy, M Earnshaw, et al.
Pageof 10